NEUROFIBROMATOSIS TYPE-2 WITHOUT VESTIBULAR SCHWANNOMA

被引:0
|
作者
MAUTNER, VF
LINDENAU, M
KOPPEN, J
HAZIM, W
KLUWE, L
机构
[1] ALLGEMEINES KRANKENHAUS OCHSENZOLL,NEUROL ABT,HAMBURG,GERMANY
[2] UNIV HAMBURG,KRANKENHAUS EPPENDORF,NEUROCHIRURG KLIN,W-2000 HAMBURG,GERMANY
[3] UNIV HAMBURG,HOSP EPPENDORF,AUGENKLIN,PLEOPT & ORTHOPT ABT,HAMBURG,GERMANY
来源
ZENTRALBLATT FUR NEUROCHIRURGIE | 1995年 / 56卷 / 02期
关键词
NEUROFIBROMATOSIS TYPE 2; MUTATION ANALYSIS; CHROMOSOME; 22; LINKAGE ANALYSIS; ATYPICAL NEUROFIBROMATOSIS TYPE 2; VESTIBULAR SCHWANNOMA;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Bilateral vestibular schwannomas (VSs) are the hallmark of neurofibromatosis type 2 and the crucial criteria for the diagnosis of this autosomal dominant disorder according to the criteria of the National Institutes of Health Consensus Statement. We describe three patients without VSs aged 47, 52 and 69 years, in whom a NF2 gene carrier status was diagnosed by spinal tumors, a cataract and schwannoma of cranial and peripheral nerves. In one case the diagnosis was ascertained by mutation analysis, which revealed a 163bp deletion in the NF2 cDNA, and by the fact that two daughters had the same deletion and NF2 according to the NIH criteria. Our finding suggests that patients with spinal tumors, multiple brain tumors, associated neurinomas or cataract might be carriers of a mutated NF2-gene. The study suggests that the NIH criteria are too restrictive, since NF2 seems to show up for a broader spectrum of phenotypes.
引用
收藏
页码:83 / 87
页数:5
相关论文
共 50 条
  • [41] Facial Nerve Outcomes After Vestibular Schwannoma Microsurgical Resection in Neurofibromatosis Type 2
    Sobieski, Catherine
    Killeen, Daniel E.
    Barnett, Samuel L.
    Mickey, Bruce E.
    Hunter, Jacob B.
    Isaacson, Brandon
    Kutz, Joe Walter
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2021, 164 (04) : 850 - 858
  • [42] Radiotherapy in patients with vestibular schwannoma and neurofibromatosis type 2: clinical results and review of the literature
    Wagner, Johanna
    Welzel, Thomas
    Habermeh, Daniel
    Debus, Juergen
    Combs, Stephanie E.
    TUMORI JOURNAL, 2014, 100 (02): : 189 - 194
  • [43] The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2
    Mikkel Christian Alanin
    Camilla Klausen
    Per Caye-Thomasen
    Carsten Thomsen
    Kaare Fugleholm
    Lars Poulsgaard
    Ulrik Lassen
    Morten Mau-Sorensen
    Kenneth Francis Hofland
    European Archives of Oto-Rhino-Laryngology, 2015, 272 : 3627 - 3633
  • [44] Bevacizumab for Progressive Vestibular Schwannoma in Neurofibromatosis Type 2: A Retrospective Review of 31 Patients
    Plotkin, Scott R.
    Merker, Vanessa L.
    Halpin, Chris
    Jennings, Dominique
    McKenna, Michael J.
    Harris, Gordon J.
    Barker, Fred G., II
    OTOLOGY & NEUROTOLOGY, 2012, 33 (06) : 1046 - 1052
  • [45] The effect of bevacizumab on vestibular schwannoma tumour size and hearing in patients with neurofibromatosis type 2
    Alanin, Mikkel Christian
    Klausen, Camilla
    Caye-Thomasen, Per
    Thomsen, Carsten
    Fugleholm, Kaare
    Poulsgaard, Lars
    Lassen, Ulrik
    Mau-Sorensen, Morten
    Hofland, Kenneth Francis
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2015, 272 (12) : 3627 - 3633
  • [46] Pediatric vestibular schwannoma without evidence of neurofibromatosis: consecutive 18 microsurgical experiences
    Ken Matsushima
    Michihiro Kohno
    Norio Ichimasu
    Nobuyuki Nakajima
    Masanori Yoshino
    Child's Nervous System, 2022, 38 : 1505 - 1512
  • [47] Pediatric vestibular schwannoma without evidence of neurofibromatosis: consecutive 18 microsurgical experiences
    Matsushima, Ken
    Kohno, Michihiro
    Ichimasu, Norio
    Nakajima, Nobuyuki
    Yoshino, Masanori
    CHILDS NERVOUS SYSTEM, 2022, 38 (08) : 1505 - 1512
  • [48] Long-Term Outcomes of Stereotactic Radiosurgery for Vestibular Schwannoma Associated with Neurofibromatosis Type 2 in Comparison to Sporadic Schwannoma
    Shinya, Yuki
    Hasegawa, Hirotaka
    Shin, Masahiro
    Sugiyama, Takehiro
    Kawashima, Mariko
    Takahashi, Wataru
    Iwasaki, Shinichi
    Kashio, Akinori
    Nakatomi, Hirofumi
    Saito, Nobuhito
    CANCERS, 2019, 11 (10)
  • [49] Fractionated Stereotactic Radiotherapy Compared to Stereotactic Radiosurgery for Vestibular Schwannoma in Patients with Type 2 Neurofibromatosis
    Mauro, Geovanne Pedro
    Da Roz, Leila Maria
    Gico, Vinicius de Carvalho
    Weltman, Eduardo
    de Souza, Evandro Cesar
    Figueiredo, Eberval Gadelha
    Teixeira, Manoel Jacobsen
    WORLD NEUROSURGERY, 2023, 179 : E416 - E420
  • [50] Clinical outcome of neurofibromatosis type 2-related vestibular schwannoma: treatment strategies and challenges
    Kim, Byung Sup
    Seol, Ho Jun
    Lee, Jung-Il
    Shin, Hyung Jin
    Park, Kwan
    Kong, Doo-Sik
    Nam, Do-Hyun
    Cho, Yang-Sun
    NEUROSURGICAL REVIEW, 2016, 39 (04) : 643 - 652